Price
No data yet.
Social Signal Score
Analyst Ratings
14 analystsRevenue
$656.40M+14.87%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Norman D. Schwartz
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 7,450
- Beta
- 1.06
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 3.81
Financials
Revenue
$656.40M+14.9%Net Income
$458.60MEBITDA
$592.20M+6036.8%Free Cash Flow
$65.20M+30.7%EPS (diluted)
$17.02Shares Outstanding (diluted)
26.95M-8.8%Operating Expenses
$328.50MCash & Debt
$1.66BReturn of Capital
$0.00Revenue by Segment (annual)
$2.58BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.58B | $759.90M | $27.87 |
| 2024 | $2.57B | $-1.84B | $-65.36 |
| 2023 | $2.67B | $-637.32M | $-21.82 |
| 2022 | $2.80B | $-3.63B | $-121.79 |
| 2021 | $2.92B | $4.25B | $142.61 |
| 2020 | $2.55B | $3.81B | $127.86 |
| 2019 | $2.31B | $1.76B | $58.93 |
| 2018 | $2.29B | $361.00M | $12.10 |
| 2017 | $2.16B | $114.74M | $4.12 |
| 2016 | $2.07B | $28.13M | $0.88 |
| 2015 | $2.02B | $113.09M | $3.74 |
| 2014 | $2.18B | $88.84M | $3.08 |
| 2013 | $2.13B | $77.79M | $2.72 |
| 2012 | $2.07B | $169.23M | $5.85 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from BIO's reported EPS growth of 12.8% a year over 13 years.
- EPS in 5 years
- $50.90
- Implied price
- $559.91
- Return from $358.90
- 9.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $278.38 — -22.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 7 | 9 | 11 | 13 | 15 |
|---|---|---|---|---|---|
| 2.8% | -9.0% | -4.3% | -0.4% | 3.0% | 6.0% |
| 7.8% | -4.6% | 0.3% | 4.5% | 8.0% | 11.1% |
| 12.8% | -0.1% | 5.0% | 9.3% | 13.0% | 16.3% |
| 17.8% | 4.3% | 9.7% | 14.1% | 18.0% | 21.5% |
| 22.8% | 8.7% | 14.3% | 19.0% | 23.0% | 26.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
60-25.00%Social Signal Score
Mentions (47)
- News (RSS)fool·6d ago·Positive
BIO-key: 3 Key Takeaways for Long-Term Investors The pending $1.2 million in license renewals due in early 2027 will show whether the company's software pivot can turn profitable on schedule.
View source ↗ - News (RSS)fool·9d ago·Positive
BIO-key (BKYI) Q3 2026 Earnings Call Transcript License revenue surged as recurring software reshaped the mix.
View source ↗ - Newsglobenewswire.com·9d ago·Neutral
BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe; Hosts Call Today at 10am ET HOLMDEL, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced its third quarter (Q3'26) and nine-month (9M'26) results for the period ended September 30, 2026.
View source ↗ - Newsglobenewswire.com·11d ago·Negative
BIO-key Enters Gaming / Hospitality Market with Contract from Major U.S. Casino Resort BIO-key entered gaming & hospitality market with contract from major U.S. casino resort to deploy PortalGuard® IAM platform and Identity-Bound Biometrics.
View source ↗ - Newsseekingalpha.com·12d ago·Positive
Bio-Rad Laboratories, Inc. (BIO) Presents at 2026 UBS Global Healthcare Conference Transcript Bio-Rad Laboratories, Inc. ( BIO ) 2026 UBS Global Healthcare Conference November 10, 2026 8:00 AM EST Company Participants Roop Lakkaraju - Executive VP & CFO Conference Call Participants Douglas Schenkel - UBS Investment Bank, Research Division Presentation Douglas Schenkel UBS Investment Bank, Research Division Welcome Roop Lakkaraju, EVP and Chief Financial Officer of Bio-Rad. Roop, thank you for be…
View source ↗ - Newsglobenewswire.com·12d ago·Neutral
Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Alpha-Lactalbumin for Premium Nutrition Markets in the U.S. Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Al
View source ↗ - News (Marketaux)markets.businessinsider.com·13d ago·Negative
Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting Biodesix will present three posters and [+145 characters]
View source ↗ - Newszacks.com·13d ago·Neutral
Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention Examine the evolution of Bio-Rad's (BIO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
View source ↗ - News (RSS)fool·17d ago·Positive
Bio-Rad (BIO) Q3 2026 Earnings Call Transcript Digital PCR demand and cost cuts shaped a quarter despite academic softness.
View source ↗ - Newsglobenewswire.com·17d ago·Negative
Medicus Pharma to Present at BIO-Europe 2026 Medicus Chief Medical Officer will Highlight Company's Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs Medicus Chief Medical Officer will Highlight Company's Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs
View source ↗ - Newsmarketbeat.com·17d ago·Neutral
What Bio-Rad Laboratories (BIO) Said on Its Q3 Earnings Call Bio-Rad Laboratories NYSE: BIO reported modest third-quarter revenue growth, its first currency-neutral increase of 2026, as gains in clinical diagnostics and digital PCR instruments helped offset weakness in parts of its life sciences business.
View source ↗ - Newsseekingalpha.com·17d ago·Positive
Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript
View source ↗ - News (RSS)seekingalpha·18d ago·Neutral
Bio-Rad Laboratories, Inc. 2026 Q3 - Results - Earnings Call Presentation
View source ↗ - Newszacks.com·18d ago·Positive
Bio-Rad Laboratories (BIO) Q3 Earnings Top Estimates Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.65 per share, beating the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.26 per share a year ago.
View source ↗ - Newsprnewswire.com·19d ago·Neutral
BIO-TECHNE DECLARES DIVIDEND MINNEAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2026. The quarterly dividend will be payable November 23, 2026, to all common shareholders of record at the close of business on November 13, 2026, provided Bio-Techne's previously announced transaction with Merck KGaA, Darmstadt, Germany has not closed on or before t…
View source ↗ - Newsglobenewswire.com·19d ago·Neutral
Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal Cipher, a Prosegur Company, and BIO-key (BKYI) Announce Technology Integration to Expand Identity Security Offering Internationally, Starting in Portugal.
View source ↗ - Newsprnewswire.com·21d ago·Neutral
CJ BIO präsentiert zukunftsorientierte Lösungen für die Tierernährung auf der EuroTier 2026 /PRNewswire/ -- CJ BIO wird an der EuroTier 2026 teilnehmen, die vom 10. bis 13. November 2026 in Hannover stattfindet, um interessierten Kunden und
View source ↗ - Newsprnewswire.com·21d ago·Neutral
CJ BIO présentera ses solutions d'avenir pour la nutrition animale à EuroTier 2026 /PRNewswire/ -- CJ BIO participera à EuroTier 2026, qui se tiendra du 10 au 13 novembre 2026 à Hanovre, en Allemagne, afin de présenter ses solutions de
View source ↗ - Newsprnewswire.com·21d ago·Neutral
CJ BIO to Showcase Future-Ready Animal Nutrition Solutions at EuroTier 2026 /PRNewswire/ -- CJ BIO will participate in EuroTier 2026, taking place from November 10 to 13, 2026, in Hanover, Germany, to present its animal nutrition
View source ↗ - Newsprnewswire.com·21d ago·Neutral
CJ BIO presentará soluciones de nutrición animal orientadas al futuro en EuroTier 2026 /PRNewswire/ -- CJ BIO participará en EuroTier 2026, que se celebrará del 10 al 13 de noviembre de 2026 en Hannover, Alemania, para presentar sus soluciones de
View source ↗ - Newsglobenewswire.com·25d ago·Neutral
BIO-key Deploys Identity Security Solution to New Customer Within a Middle East Government's National Security Ecosystem RIYADH, Saudi Arabia and HOLMDEL, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global provider of Identity and Access Management (IAM) and biometric authentication solutions, today announced the deployment of its identity security solutions to an additional customer within a Middle East government's national security ecosystem.
View source ↗ - Newsprnewswire.com·31d ago·Neutral
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable
View source ↗ - Newsglobenewswire.com·31d ago·Negative
BIO-key Secures Another Middle East Government Contract for its Passwordless, Biometric, Identity and Access Management Solutions BIO-key (BKYI) secured another Middle East government contract (new customer) for its passwordless, biometric, identity & access management (IAM) solutions
View source ↗ - Newsglobenewswire.com·32d ago·Neutral
MC Services to Support BIO-Europe® 2026 in Cologne as Media Partner Munich, Düsseldorf, Germany, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Munich, Düsseldorf, October 21, 2026 - MC Services AG, a leading international corporate communications and investor relations firm for life sciences and healthcare, will support BIO-Europe 2026 as media partner. Taking place in Cologne, Germany, November 9-11, 2026, MC Services invites international, national and regional media, coordinates interview opportunities w…
View source ↗ - News (RSS)zerohedge·34d ago·Neutral
…ould demonstrate that only sweeping deregulation can substantially expand housing supply. Javier Milei is currently showing exactly how this can be done in Argentina.BIO: In June, Skyhorse Publishing will release Rainer Zitelmann's book "New Space Capitalism." Tyler Durden Mon, 10/19/2026 - 03:30
View source ↗ - Newsglobenewswire.com·40d ago·Neutral
BIO-key Names Cybersecurity Veteran Stephen Morrow President of PortalGuard to Drive Accelerated Adoption of its Innovative IAM Solution HOLMDEL, N.J., Oct. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and tokenless Identity-Bound Biometric™ (IBB) authentication, today announced the appointment of Stephen Morrow as President of PortalGuard®, the…
View source ↗ - Newsglobenewswire.com·40d ago·Neutral
BIO-key Adds New Middle East Government Security Agency Customer, Expanding Regional Footprint BIO-key (BKYI) Adds New Middle East Government Security Agency, Expands Regional Footprint, Supports National Digital Transformation & Cybersecurity goals.
View source ↗ - Newsglobenewswire.com·46d ago·Neutral
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform Presentation to feature results from first clinical study of ART26.12 and highlight the potential of FABP5 inhibition across multiple indications
View source ↗ - Newsglobenewswire.com·54d ago·Neutral
BIO-key Partners with Al Majlis Group to Expand Identity Security Across Arabian Gulf BIO-key (BKYI) Partners with Al Majlis Group, Founded by His Excellency Dherar Belhoul Al Falasi, to Expand Identity Security Across Arabian Gulf Region.
View source ↗ - Newsglobenewswire.com·55d ago·Neutral
… Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magnetic Beads - Global Strategic Business Report" has been added to ResearchAndMarkets. com's offering. The global magnetic beads market was valued at an estimated US$3. 3 billion in 2025 and is projected to reach US$7.
View source ↗ - Newsmarketbeat.com·57d ago·Neutral
Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth Bio-Rad Laboratories NYSE: BIO is pursuing a multi-year effort to improve growth, expand margins and strengthen free cash flow, with management emphasizing portfolio focus, operating discipline and a more selective approach to acquisitions.
View source ↗ - Newsseekingalpha.com·59d ago·Positive
Bio-Rad Laboratories, Inc. (BIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript Bio-Rad Laboratories, Inc. (BIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
View source ↗ - Newszacks.com·60d ago·Negative
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now BIO's Clinical Diagnostics strength and international reach support growth, while China weakness, geopolitics and FX remain key risks.
View source ↗ - Newsglobenewswire.com·60d ago·Neutral
BIO-key Receives FIDO Alliance Full Certification for Passkey:YOU™ Authentication, Unlocking New Markets Including Agentic AI Authenticated Controls HOLMDEL, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and tokenless Identity-Bound Biometrics™ (IBB) authentication, today announced that its Passkey:YOU™ authenticator has received Full…
View source ↗ - Newsseekingalpha.com·73d ago·Positive
Bio-Rad: Favorable Read-Across From Investor Event Bio-Rad Laboratories (BIO) remains a Buy, after my assessment of relevant corporate disclosures at the recent Wells Fargo Healthcare conference. Management targets long-term operating margins of 20%, with intermediate milestones in the mid-teens, outpacing consensus expectations. Margin drivers include cost rationalization, AI-driven efficiencies, and a shift toward higher-margin consumables revenue.
View source ↗ - Newsseekingalpha.com·74d ago·Positive
Bio-Rad Laboratories, Inc. (BIO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Bio-Rad Laboratories, Inc. (BIO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - Newsglobenewswire.com·79d ago·Neutral
INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives NEW YORK and TOKYO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.
View source ↗ - 4chan /biz/biz·80d ago·Positive
because you ure supposed to buy BIO and aster to 1000x phag its all about biotech and most powerful dex (yes hype is dead)
View source ↗ - News (RSS)hellenicshipping·87d ago·Positive
BIO-UV Upgrades Bio-Sea Control Panel With Traffic Light System BIO-UV Group has upgraded the control system for its BIO-SEA ballast water management system (BWMS), introducing new features to help crews identify changes in treatment capacity and filter performance when operating in challenging water conditions. The new BIO-SEA control panel, officially unveiled for the first time at the SMM 2026 exhibition in Hamburg, features a ...
View source ↗ - 4chan /biz/biz·93d ago·Neutral
link is dead, RED stone is the new link, it gained the biggest momentum surpasing any btc dominance corrections. Same will do ENA and BIO, fastest growing. if you dont own winners, u gon lose /thread
View source ↗ - Newszacks.com·93d ago·Positive
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation? BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.
View source ↗ - Newszacks.com·94d ago·Positive
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building? BIO's 19.1% monthly rally is backed by digital PCR gains and steadier diagnostics, but weak Life Science demand and a rich valuation loom.
View source ↗ - Newsglobenewswire.com·101d ago·Neutral
BIO-key's Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET BIO-key's (BKYI)Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally.
View source ↗ - Newsglobenewswire.com·102d ago·Positive
BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE KUALA LUMPUR, MALAYSIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced second quarter financial results and provided a business update.
View source ↗ - News (RSS)seekingalpha·103d ago·Neutral
BIO-key International enters $2.5M warrant inducement transaction
View source ↗ - Newszacks.com·104d ago·Neutral
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock Explore Bio-Rad's (BIO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
View source ↗ - Newsglobenewswire.com·104d ago·Neutral
Portuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity Security Portuguese national security agency selects BIO-key (BKYI) and Visualforma to strengthen identity security with advanced IAM and biometric authentication.
View source ↗
Earnings
Thu, Feb 11(in 3 months)
Consensus estimate $2.83 per share
Typical surprise +18.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 4$2.65 vs $2.23beat
- Tue, Aug 4$2.62 vs $1.75beat
- Thu, Apr 30$1.89 vs $1.97miss
- Thu, Feb 12$2.51 vs $2.57miss
- Wed, Oct 29$2.26 vs $2.30miss
- Thu, Jul 31$2.61 vs $1.93beat
Estimates and results for BIO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BIO officers and directors.
- Bought
- —
- Sold
- $1.4m
0 trades
4 trades
- Enloe Courtney Csold
- Divincenzo Jonathan P.sold
- Barry Jamessold
- Engelhardt Eva Anettesold
96 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Dec 6, 2023 (33d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (13d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (37d later)Buy$1,001 - $15,000
- Lois Frankelhouse · FL22 · disclosed Oct 10, 2023 (32d later)Sell$1,001 - $15,000
- Lois Frankelhouse · FL22 · disclosed Jul 28, 2023 (30d later)Buy$1,001 - $15,000
- Lois Frankelhouse · FL22 · disclosed Jul 28, 2023 (29d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 11, 2023 (12d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Dec 29, 2022 (29d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2022 (33d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 10, 2022 (21d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 7, 2022 (20d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 10, 2022 (31d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed May 6, 2022 (23d later)Sell$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Apr 8, 2022 (9d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 8, 2022 (19d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 8, 2022 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 8, 2022 (19d later)Buy$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Jul 23, 2021 (116d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Feb 10, 2021 (36d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Dec 8, 2020 (67d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
